IMPORTANCE: Management of pancreatic cancer is complex, requiring coordination of multiple providers. National Comprehensive Cancer Network guidelines, developed for standardization and quality improvement, recommend a multimodal approach. OBJECTIVE: This study analyzed national rates of compliance with National Comprehensive Cancer Network recommendations, assessed factors affecting compliance, and evaluated whether compliance with evidence-based guidelines improved overall survival. DESIGN: This is a retrospective review of adults diagnosed with pancreatic cancer entered into the National Cancer Database. Patients included had stage I and II pancreatic cancer, and complete data in the database. Patients were classified as compliant if they underwent both surgery and a second treatment modality (chemotherapy, radiation, or chemoradiation). Clinico-pathologic variables were analyzed using univariate and multivariate models to predict overall survival. SETTING: Hospital-based national study population. PARTICIPANTS: Patients with stage I or II pancreatic cancer. MAIN OUTCOMES AND MEASURES: Compliance with National Comprehensive Cancer Network recommendations, factors affecting compliance, and overall survival based on compliance. RESULTS: A total of 52,450 patients were included; 19,272 patients (37%) were compliant. Patients were found to be most compliant in the 50-59-year-old range (49% complaint), with decreased compliance at the extremes of age. Male patients were more compliant than female patients (39 vs 34%, p < 0.0001). Caucasians were more compliant (39%) than African Americans (32%) or other races (32%, p < 0.0001). Patients treated at academic/research centers were more compliant than patients treated at other facilities (39% compliant, p < 0.0001). Patients with stage II disease were more compliant compared with stage I disease (43 vs 18%, p < 0.0001). Compliance was shown to improve overall survival (p < 0.0001). CONCLUSION: Adherence to National Comprehensive Cancer Network guidelines for pancreatic cancer patients improves survival. Compliance nationwide is low, especially for older patients and minorities and those treated outside academic centers. More studies will need to be performed to identify factors that hinder compliance.
IMPORTANCE: Management of pancreatic cancer is complex, requiring coordination of multiple providers. National Comprehensive Cancer Network guidelines, developed for standardization and quality improvement, recommend a multimodal approach. OBJECTIVE: This study analyzed national rates of compliance with National Comprehensive Cancer Network recommendations, assessed factors affecting compliance, and evaluated whether compliance with evidence-based guidelines improved overall survival. DESIGN: This is a retrospective review of adults diagnosed with pancreatic cancer entered into the National Cancer Database. Patients included had stage I and II pancreatic cancer, and complete data in the database. Patients were classified as compliant if they underwent both surgery and a second treatment modality (chemotherapy, radiation, or chemoradiation). Clinico-pathologic variables were analyzed using univariate and multivariate models to predict overall survival. SETTING: Hospital-based national study population. PARTICIPANTS: Patients with stage I or II pancreatic cancer. MAIN OUTCOMES AND MEASURES: Compliance with National Comprehensive Cancer Network recommendations, factors affecting compliance, and overall survival based on compliance. RESULTS: A total of 52,450 patients were included; 19,272 patients (37%) were compliant. Patients were found to be most compliant in the 50-59-year-old range (49% complaint), with decreased compliance at the extremes of age. Male patients were more compliant than female patients (39 vs 34%, p < 0.0001). Caucasians were more compliant (39%) than African Americans (32%) or other races (32%, p < 0.0001). Patients treated at academic/research centers were more compliant than patients treated at other facilities (39% compliant, p < 0.0001). Patients with stage II disease were more compliant compared with stage I disease (43 vs 18%, p < 0.0001). Compliance was shown to improve overall survival (p < 0.0001). CONCLUSION: Adherence to National Comprehensive Cancer Network guidelines for pancreatic cancerpatients improves survival. Compliance nationwide is low, especially for older patients and minorities and those treated outside academic centers. More studies will need to be performed to identify factors that hinder compliance.
Authors: Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess Journal: JAMA Date: 2007-01-17 Impact factor: 56.272
Authors: Carol M Lewis; Amy C Hessel; Dianna B Roberts; Yunxia Z Guo; F Christopher Holsinger; Lawrence E Ginsberg; Adel K El-Naggar; Randal S Weber Journal: Arch Otolaryngol Head Neck Surg Date: 2010-12
Authors: Margaret A O'Grady; Elyse Slater; Elin R Sigurdson; Neal J Meropol; Alan Weinstein; Charles J Lusch; Elaine Sein; Patricia Keeley; Bonnie Miller; Paul F Engstrom; Steven J Cohen Journal: Clin Colorectal Cancer Date: 2011-04-22 Impact factor: 4.481
Authors: David J Worhunsky; Yifei Ma; Yulia Zak; George A Poultsides; Jeffrey A Norton; Kim F Rhoads; Brendan C Visser Journal: J Natl Compr Canc Netw Date: 2015-03 Impact factor: 11.908
Authors: Brendan C Visser; Yifei Ma; Yulia Zak; George A Poultsides; Jeffrey A Norton; Kim F Rhoads Journal: HPB (Oxford) Date: 2012-06-12 Impact factor: 3.647
Authors: David A Kooby; Theresa W Gillespie; Yuan Liu; Johnita Byrd-Sellers; Jerome Landry; John Bian; Joseph Lipscomb Journal: Ann Surg Oncol Date: 2013-06-15 Impact factor: 5.344
Authors: Lennart B van Rijssen; Lydia G M van der Geest; Thomas L Bollen; Marco J Bruno; Ate van der Gaast; Laetitia Veerbeek; Fibo J W Ten Kate; Olivier R C Busch Journal: Pancreatology Date: 2015-10-26 Impact factor: 3.996
Authors: P Wille-Jørgensen; P Sparre; A Glenthøj; S Holck; L Nørgaard Petersen; H Harling; H Stub Højen; S Bülow Journal: Colorectal Dis Date: 2013-04 Impact factor: 3.788
Authors: Benjamin D Powers; James McDonald; Rahul Mhaskar; Simon J Craddock Lee; Jennifer B Permuth; Susan Vadaparampil; Scott M Gilbert; Jason W Denbo; Dae Won Kim; Jose M Pimiento; Pamela J Hodul; Mokenge P Malafa; Daniel A Anaya; Jason B Fleming Journal: Ann Surg Open Date: 2022-08-17